MoneyWorks4Me

Raymed Labs - Quaterly Results

24 May 2024 Evaluate
The revenue slipped marginally during the March 2024 quarter. A decline of about Rs. 0.00 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2024 is Rs. -0.52 millions as compared to Net Loss of Rs. -0.79 millions of corresponding quarter ended March 2023 Operating profit Margin for the quarter ended March 2024 improved to -0.50% as compared to -0.77% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.21 0.00 0.00 0.21 0.00 0.00 0.21 0.00
PBIDT -0.50 -0.77 -35.06 -0.97 -1.65 -41.21 -0.97 -1.65 -41.21
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.50 -0.77 -35.06 -0.97 -1.65 -41.21 -0.97 -1.65 -41.21
Depreciation 0.02 0.02 0.00 0.05 0.06 -16.67 0.05 0.06 -16.67
PBT -0.52 -0.79 -34.18 -1.02 -1.71 -40.35 -1.02 -1.71 -40.35
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.52 -0.79 -34.18 -1.02 -1.71 -40.35 -1.02 -1.71 -40.35
Equity 42.74 42.74 0.00 42.74 42.74 0.00 42.74 42.74 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Uflex 663.05
EPL 238.55
AGI Greenpac 803.90
Huhtamaki India 242.40
TCPL Packaging 4107.35
View more..